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The effect of murine cytomegalovirus on myelopoiesis was studied in long-term bone marrow culture to find
an in vitro correlate for the lethal virus interference with bone marrow reconstitution (W. Mutter, M. J.
Reddehase, F. W. Busch, H.-J. Buhring, and U. H. Koszinowski, J. Exp. Med. 167:1645-1658, 1988). The in
vitro generation of granulocyte-monocyte progenitors (CFU-GM) discontinued after infection of the stromal
cell layer, whereas the proliferation and differentiation of CFU-GM to granulocyte-monocyte colonies remained
unaffected. A protocol was established to probe the functional integrity of earlier hematopoietic cells.
Pre-CFU-GM (the progenitors of the CFU-GM) could be recovered from an infected bone marrow donor
culture by transfer onto an inductive recipient stromal cell layer. Thus, at least in vitro, infection of bone
marrow stroma appears to be the only cause of the defect in myelopoiesis.
Clinical cytomegalovirus (CMV) infection endangers im-
munocompromised bone marrow transplant patients not
only by causing interstitial pneumonia and other severe
organ manifestations (8) but also by contributing actively by
myelosuppression to the maintenance of an immunode-
pressed state and to graft failure (3, 11, 15). Perturbation of
stromal cell functions critical for myelopoiesis as well as
infection of cells of the myeloid lineage have been consid-
ered for an explanation. A recent study by Simmons and
colleagues (18) on the effect of human CMV on in vitro
hematopoiesis in long-term bone marrow culture (LTBMC)
has shown that clinical CMV isolates can be grouped into
two main classes. Two-thirds of the isolates re;embled the
laboratory strain AD169 in its tropism for fibroblastlike
stromal cells (2, 18), whereas one-third affected myelopoie-
sis directly by infection of myeloid progenitors (18). Whether
comparable mechanisms are operating in vivo is difficult to
ascertain for human CMV disease.
We have been working on CMV pathogenesis in a mouse
model (reviewed in reference 5) and previously documented
a lethal in vivo interference of murine CMV infection with
hematopoietic reconstitution (9). In that study, an inhibitory
effect on myelopoiesis became manifested not only as a
failure in the production of the direct progenitors of granu-
locytes and monocytes, the granulocyte-monocyte CFU
(CFU-GM), but also as a failure in the regeneration of day 14
spleen colony-forming stem cells, which are considered to
precede the CFU-GM in the myeloid lineage (reviewed in
references 6 and 14). Therefore, infection of stem cells,
infection of stromal cells that are required for supporting
stem cell self-renewal and differentiation (1, 20), or both may
account for the defective myelopoiesis. The specific aim of
the present study was to distinguish between these possibil-
ities in an in vitro model. To know whether a defect has a
single cause or multiple causes is not only of theoretical
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interest but also of relevance for trials of a therapeutic
intervention.
Cessation of CFU-GM production after CMV infection of
LTBMC. LTBMC were established basically according to
the Dexter protocol (4, 19) by seeding 3 x 106 bone marrow
cells (BMC) in a volume of 3 ml in polypropylene tissue
culture flasks. After 2 weeks, when an adherent cell layer
composed of monocytic and endothelial-like cells as well as
adipocytes and fibroblasts (1, 4, 12) had developed and
clusters of proliferating hematopoietic cells in the form of
cobblestone areas became discernible, cultures were in-
fected with the ATCC VR-194 Smith strain of murine CMV.
From then on, virus replication and CFU-GM content were
monitored at 4-day intervals (Fig. 1). By day 4, after an
initial drop in inoculum virus titer, intrinsic virus replication
started and peaked around day 12, at which time the adher-
ent stromal cell layer was visibly destroyed. As a coincident
event, CFU-GM production ceased after day 4. By contrast,
in the absence of CMV infection, CFU-GM content in-
creased until by 1 month after the cultures were initiated, a
plateau level was reached.
It became clear from these findings that CMV can produc-
tively infect bone marrow stroma and inhibit myelopoiesis in
a system involving only hematopoietic and stromal BMC.
Since in vitro hematopoiesis is known to be stroma depen-
dent (1, 4, 19, 20), the observation that the production of
CFU-GM in LTBMC did not continue on a destroyed
stromal cell layer as shown here for murine CMV and
previously for human CMV (2) could not come as a surprise.
Yet, the question remained whether the stromal defect was
the only reason for the failure in myelopoiesis.
CMV infection does not prevent the development of granu-
locyte-monocyte colonies from CFU-GM. Declining CFU-GM
content in LTBMC (Fig. 1) could indicate not only a stop in
production but also that previously generated CFU-GM
were infected. CFU-GM cannot be quantitated directly but
only by counting their clonal progeny, namely, granulocyte-
monocyte colonies that develop in soft gel hematopoietic
progenitor assay cultures supplemented with hemopoietins
(7, 14). CMV could interrupt this development at any stage.
This possibility was tested by incubating BMC in suspen-
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FIG. 1. Kinetics of virus production and CFU-GM content after
infection of LTBMC. A total of 42 replicate Dexter LTBMC (4, 19)
were established. Medium was renewed after week 1, and after 2
weeks, one-half of the cultures were infected. At 4-day intervals,
nonadherent cells from three cultures of each of the two groups were
harvested and CFU-GM were quantitated in a progenitor assay.
Data represent granulocyte-macrophage colonies from 5 x 104
LTBMC cells counted in triplicate assay cultures and multiplied by
the average yield of hematopoietic cells in the three LTBMC. For
infected LTBMC, the virus titer was determined by a plaque assay
(17) from the entire culture content after freezing and thawing. Data
represent the median of three determinations.
sion for up to 3 days with CMV at multiplicities of infection
ranging from 0.1 to 10 before CFU-GM were quantitated in
progenitor assay cultures supplemented with WEHI 3B-
conditioned medium as a source of colony-stimulating fac-
tors. At no dose of CMV and after no period of preincuba-
tion of BMC could an inhibition of GM colony formation be
observed (Fig. 2).
Salivary gland preparations of murine CMV are myelosup-
pressive in the absence of viral infectivity. The message of
Fig. 2 was inconsistent with previous data of Petursson et al.
(13), who did conceptually the same experiment but found a
significant reduction in granulocyte-macrophage colony for-
mation, which led them to conclude that murine CMV can
cause myelosuppression by direct infection of progenitor
cells. These investigators had used the Osborn derivative of
the Smith strain of murine CMV propagated in salivary
glands and added to BMC as diluted tissue homogenate,
while we worked with the ATCC virus propagated in mouse
embryo fibroblasts and purified. In the light of the recent
experience that clinical isolates of human CMV differ in their
cell tropism (18), the reported difference in virulence be-
tween salivary gland isolates of murine CMV and the tissue-
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FIG. 2. Exposure of BMC to CMV. Samples of 106 femoral BMC
were exposed to CMV at the indicated multiplicities of infection
(MOI) for up to 3 days. CFU-GM numbers were determined in
triplicate. Median value and range are indicated. G/M, Granulocyte-
macrophage.
culture virus (10) had to be considered as a possible reason
for the discrepant results.
We therefore repeated the experiments with a salivary
gland preparation of the ATCC CMV and also confirmed
with this virus a dose-dependent inhibition of granulocyte-
macrophage colony formation that was significantly stronger
than the negative effect seen with control preparations from
salivary glands of age-matched noninfected donors (Table 1).
Yet, a preparation in which viral infectivity was abolished by
inactivation with UV light remained as suppressive as the
infectious preparation. UV light treatment of the tissue
culture virus did not induce a suppressive property (data not
shown).
It is beyond the scope of this report to identify the
suppressive principle that is clearly not infectious CMV and
that is present in infected but not, or to a lesser extent, in
noninfected salivary gland tissue. One might think of cyto-
kines that are released only by infected cells or by leuko-
cytes infiltrating the infected tissue. The fact that salivary
gland preparations of murine CMV are myelosuppressive in
the absence of viral infectivity should be considered when-
ever such preparations are used or have been used for
studying the pathogenesis of murine CMV.
Myeloid lineage-committed preprogenitor cells can be re-
covered from infected LTBMC. The question of whether
inhibition of myelopoiesis is caused by infection of hemato-
poietic stem cells has not yet been adequately addressed for
either murine or human CMV. The experimental regimen of
our approach to the problem is outlined in Fig. 3.
Long-term bone marrow culture
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TABLE 1. Inhibition of granulocyte-macrophage colony
formation by salivary gland isolate of murine CMV"
Granulocyte-
macrophage colonies
CMV prepb PFU (MOIC) from 106 BMC
Day 1 Day 3
No CMV 0 (0) 1,660 1,260
TC-CMV 1 x 107 (10) 1,780 1,340
SGH-CMV (1:10) 2 x 106 (2) 0 0
SGH-CMV (1:100) 2 x 105 (0.2) 780 640
SGH (1:10) 0 (0) 540 300
SGH (1:100) 0 (0) 1,160 660
SGH-CMVi (1:10) 0 (0) 0 0
a BMC (106) from normal BALB/c donors were incubated with CMV or
control preparations. CFU-GM assay cultures were set up at day 1 or day 3
postinfection, and granulocyte-macrophage colonies were determined 8 days
later. Data represent colonies from 5 x 104 BMC counted in triplicate cultures
and multiplied by a factor of 20.
b TC-CMV, Sucrose gradient-purified tissue culture (mouse embryo fibro-
blast) CMV; SGH-CMV, 1:10-diluted salivary gland homogenate from in-
fected 3-week-old BALB/c donors (the titer of the virus stock was 2 x 107
PFU/ml); SGH, 1:10-diluted salivary gland homogenate from noninfected
donors; SGH-CMVi, SGH-CMV inactivated by UV light.
' MOI, Multiplicity of infection.
LTBMC were established and either infected after 2
weeks or left uninfected as a control (Fig. 3, top line). As
documented in the original report (4), LTBMC consist of an
adherent stromal cell layer, of hematopoietic progenitor cells
that per definition cannot self-renew, and of hematopoietic
stem cells. Because we identified stem cells not by spleen
colony formation but by their ability to give rise to CFU-
GM, a progenitor cell type, we named them preprogenitors
or pre-CFU-GM to describe more accurately what had been
measured. Within 4 days of infection, the production rate of
CFU-GM had already declined (recall Fig. 1), which could
result from infection of the stroma, of the pre-CFU-GM, or
both. If the functional integrity of pre-CFU-GM was not
affected by either infection or a deprivation of stromal
support during the 4 days of exposure to CMV, the pre-
CFU-GM should be able to generate CFU-GM after transfer
onto a functional stromal layer (Fig. 3, center line). The
recipient inductive stroma was established in a regular
LTBMC, from which the nonadherent hematopoietic cells
were washed off after they had been inactivated by irradia-
tion (20). Residual intrinsic hematopoiesis was not detect-
able in the recipient cultures (data not shown). To preclude
infection of the recipient stroma by free CMV, nonadherent
hematopoietic donor culture cells were incubated with
CMV-neutralizing antiserum and sedimented through a se-
rum cushion before they were transferred. CFU-GM produc-
tion in the recipient cultures was assessed by quantitating
CFU-GM (Fig. 3, bottom line) before (CFU-GM input) and
after (CFU-GM output) an 8-day period of in vitro he-
matopoiesis.
The results compiled in Table 2 make it clear that the rate
of CFU-GM production on the recipient stroma is indepen-
dent of an infection in the donor cultures. Thus, apparently,
pre-CFU-GM were neither destroyed by productive infec-
tion nor was their functional integrity damaged by a short-
term deprivation of stromal support. The functional data do
not exclude latent infection of pre-CFU-GM that may result
in reactivation at later stages of differentiation. The cellular
site of CMV latency has not yet been identified in any tissue
or, specifically, in bone marrow. Consequently, the physical
state of the viral genome and viral gene expression during
latency are still undefined. Testing this for pre-CFU-GM is
not trivial, because these cells have a very low frequency in
bone marrow and because there is to date no protocol for
purifying them preparatively. We can, however, draw an
important conclusion from the findings presented here. If
pre-CFU-GM were indeed latently infected, then latent
infection did not disturb their capacity to give rise to
colonies of differentiated progeny.
Conclusion. With respect to the in vitro effects on bone
marrow stroma and on hematopoietic progenitor cells, the
+/- CMV
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FIG. 3. Experimental regimen and time schedule for preprogenitor transfer onto inductive bone marrow stroma. d, Days; G/M,
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TABLE 2. Rescue of pre-CFU-GM from CMV-infected LTBMC'
Preprogenitor recipient
Expt culture %
(no. of cultures) Input Output Amplification
CFU-GM CFU-GM
+CMV
1 (1) 561 1,338 239
2 (1) 441 1,278 290
3 (6) 549 840 153
963 175
1,737 316
693 126
954 174
1,080 197
Mean 209
Median 186
-CMV (3 (3)) 882 2,115 240
1,341 152
1,803 204
Mean 199
Median 204
a For experimental regimen and time schedule, see Fig. 3. Data represent
granulocyte-macrophage colonies from 5 x 104 nonadherent LTBMC cells
counted in triplicate assay cultures and multiplied by the yield of nonadherent
cells per donor (input CFU-GM) or recipient (output CFU-GM) culture.
data obtained with murine CMV are in line with the proper-
ties described for the human CMV laboratory strain AD169
and the majority of clinical isolates (2, 18). This fact encour-
ages the use of the mouse model for studying CMV-mediated
myelosuppression in the infected host, in which, in addition
to intrinsic effects of CMV within bone marrow, tissue
lesions in several organs (17) including hormonal glands (16)
may also account for extrinsic negative influences on he-
matopoiesis. The new information is that murine CMV does
not interfere with proliferation and differentiation of prepro-
genitors of the myelopoietic lineage. The in vitro he-
matopoiesis transfer protocol used here to probe preprogen-
itor function should also be applicable for further
investigating the inhibition of human myelopoiesis by CMV.
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